Since CA9 is linked to stemness in breast and GBM CSC [57–59], we performed Western-Blot analysis of stem markers Olig2, Sox2, and Nestin in SRC3, D1, G, and I GSC following CA9 inhibition via shRNA. This evidence concerns the gene OLIG2 and glioblastoma.